nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Methylprednisolone—ankylosing spondylitis	0.183	0.357	CrCtD
Exemestane—Prednisone—ankylosing spondylitis	0.167	0.326	CrCtD
Exemestane—Prednisolone—ankylosing spondylitis	0.163	0.318	CrCtD
Exemestane—CYP19A1—Betamethasone—ankylosing spondylitis	0.0636	0.422	CbGbCtD
Exemestane—CYP19A1—Dexamethasone—ankylosing spondylitis	0.037	0.246	CbGbCtD
Exemestane—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0124	0.0823	CbGbCtD
Exemestane—Testolactone—Methylprednisolone—ankylosing spondylitis	0.0108	0.0362	CrCrCtD
Exemestane—Testolactone—Betamethasone—ankylosing spondylitis	0.0106	0.0356	CrCrCtD
Exemestane—Testolactone—Dexamethasone—ankylosing spondylitis	0.0106	0.0356	CrCrCtD
Exemestane—Testolactone—Triamcinolone—ankylosing spondylitis	0.0104	0.0348	CrCrCtD
Exemestane—Testolactone—Prednisone—ankylosing spondylitis	0.00985	0.033	CrCrCtD
Exemestane—Prednisone—Methylprednisolone—ankylosing spondylitis	0.00966	0.0324	CrCrCtD
Exemestane—Testolactone—Prednisolone—ankylosing spondylitis	0.00961	0.0322	CrCrCtD
Exemestane—Prednisone—Dexamethasone—ankylosing spondylitis	0.00951	0.0319	CrCrCtD
Exemestane—Prednisone—Betamethasone—ankylosing spondylitis	0.00951	0.0319	CrCrCtD
Exemestane—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00939	0.0624	CbGbCtD
Exemestane—Prednisone—Triamcinolone—ankylosing spondylitis	0.00929	0.0312	CrCrCtD
Exemestane—Fluprednidene Acetate—Methylprednisolone—ankylosing spondylitis	0.00898	0.0301	CrCrCtD
Exemestane—Loteprednol—Methylprednisolone—ankylosing spondylitis	0.00898	0.0301	CrCrCtD
Exemestane—Fluprednidene Acetate—Betamethasone—ankylosing spondylitis	0.00883	0.0296	CrCrCtD
Exemestane—Loteprednol—Dexamethasone—ankylosing spondylitis	0.00883	0.0296	CrCrCtD
Exemestane—Fluprednidene Acetate—Dexamethasone—ankylosing spondylitis	0.00883	0.0296	CrCrCtD
Exemestane—Loteprednol—Betamethasone—ankylosing spondylitis	0.00883	0.0296	CrCrCtD
Exemestane—Loteprednol—Triamcinolone—ankylosing spondylitis	0.00863	0.0289	CrCrCtD
Exemestane—Fluprednidene Acetate—Triamcinolone—ankylosing spondylitis	0.00863	0.0289	CrCrCtD
Exemestane—Prednisone—Prednisolone—ankylosing spondylitis	0.00861	0.0289	CrCrCtD
Exemestane—Methylprednisolone—Dexamethasone—ankylosing spondylitis	0.00826	0.0277	CrCrCtD
Exemestane—Methylprednisolone—Betamethasone—ankylosing spondylitis	0.00826	0.0277	CrCrCtD
Exemestane—Prednisolone—Methylprednisolone—ankylosing spondylitis	0.00821	0.0275	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisone—ankylosing spondylitis	0.00819	0.0275	CrCrCtD
Exemestane—Loteprednol—Prednisone—ankylosing spondylitis	0.00819	0.0275	CrCrCtD
Exemestane—Prednisolone—Dexamethasone—ankylosing spondylitis	0.00808	0.0271	CrCrCtD
Exemestane—Prednisolone—Betamethasone—ankylosing spondylitis	0.00808	0.0271	CrCrCtD
Exemestane—Methylprednisolone—Triamcinolone—ankylosing spondylitis	0.00807	0.027	CrCrCtD
Exemestane—CYP3A4—Betamethasone—ankylosing spondylitis	0.00806	0.0535	CbGbCtD
Exemestane—Fluprednidene Acetate—Prednisolone—ankylosing spondylitis	0.008	0.0268	CrCrCtD
Exemestane—Loteprednol—Prednisolone—ankylosing spondylitis	0.008	0.0268	CrCrCtD
Exemestane—CYP3A4—Prednisolone—ankylosing spondylitis	0.00795	0.0528	CbGbCtD
Exemestane—Prednisolone—Triamcinolone—ankylosing spondylitis	0.0079	0.0265	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—ankylosing spondylitis	0.00766	0.0257	CrCrCtD
Exemestane—CYP3A4—Prednisone—ankylosing spondylitis	0.00751	0.0499	CbGbCtD
Exemestane—Prednisolone—Prednisone—ankylosing spondylitis	0.00749	0.0251	CrCrCtD
Exemestane—Methylprednisolone—Prednisolone—ankylosing spondylitis	0.00747	0.025	CrCrCtD
Exemestane—Testosterone—Prednisolone—ankylosing spondylitis	0.00747	0.025	CrCrCtD
Exemestane—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00469	0.0311	CbGbCtD
Exemestane—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	9.04e-05	0.00236	CcSEcCtD
Exemestane—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	9.04e-05	0.00236	CcSEcCtD
Exemestane—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	8.88e-05	0.00232	CcSEcCtD
Exemestane—Sweating increased—Prednisone—ankylosing spondylitis	8.77e-05	0.00229	CcSEcCtD
Exemestane—Visual impairment—Methylprednisolone—ankylosing spondylitis	8.77e-05	0.00229	CcSEcCtD
Exemestane—Osteoarthritis—Methotrexate—ankylosing spondylitis	8.71e-05	0.00227	CcSEcCtD
Exemestane—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	8.45e-05	0.0022	CcSEcCtD
Exemestane—Haemoglobin—Dexamethasone—ankylosing spondylitis	8.32e-05	0.00217	CcSEcCtD
Exemestane—Haemoglobin—Betamethasone—ankylosing spondylitis	8.32e-05	0.00217	CcSEcCtD
Exemestane—Haemorrhage—Dexamethasone—ankylosing spondylitis	8.27e-05	0.00216	CcSEcCtD
Exemestane—Haemorrhage—Betamethasone—ankylosing spondylitis	8.27e-05	0.00216	CcSEcCtD
Exemestane—Immune system disorder—Methylprednisolone—ankylosing spondylitis	8.22e-05	0.00214	CcSEcCtD
Exemestane—Weight increased—Prednisone—ankylosing spondylitis	8.19e-05	0.00214	CcSEcCtD
Exemestane—Depression—Prednisone—ankylosing spondylitis	8e-05	0.00209	CcSEcCtD
Exemestane—Visual impairment—Betamethasone—ankylosing spondylitis	7.97e-05	0.00208	CcSEcCtD
Exemestane—Visual impairment—Dexamethasone—ankylosing spondylitis	7.97e-05	0.00208	CcSEcCtD
Exemestane—Mental disorder—Methylprednisolone—ankylosing spondylitis	7.97e-05	0.00208	CcSEcCtD
Exemestane—Acute coronary syndrome—Prednisone—ankylosing spondylitis	7.91e-05	0.00207	CcSEcCtD
Exemestane—Myocardial infarction—Prednisone—ankylosing spondylitis	7.87e-05	0.00205	CcSEcCtD
Exemestane—Neuropathy peripheral—Prednisone—ankylosing spondylitis	7.87e-05	0.00205	CcSEcCtD
Exemestane—Malaise—Prednisolone—ankylosing spondylitis	7.79e-05	0.00203	CcSEcCtD
Exemestane—Back pain—Triamcinolone—ankylosing spondylitis	7.68e-05	0.002	CcSEcCtD
Exemestane—Hypertension—Prednisolone—ankylosing spondylitis	7.45e-05	0.00195	CcSEcCtD
Exemestane—Alopecia—Dexamethasone—ankylosing spondylitis	7.31e-05	0.00191	CcSEcCtD
Exemestane—Alopecia—Betamethasone—ankylosing spondylitis	7.31e-05	0.00191	CcSEcCtD
Exemestane—Haemoglobin—Prednisone—ankylosing spondylitis	7.24e-05	0.00189	CcSEcCtD
Exemestane—Haemorrhage—Prednisone—ankylosing spondylitis	7.21e-05	0.00188	CcSEcCtD
Exemestane—Malaise—Triamcinolone—ankylosing spondylitis	7.16e-05	0.00187	CcSEcCtD
Exemestane—Malaise—Methylprednisolone—ankylosing spondylitis	7.14e-05	0.00186	CcSEcCtD
Exemestane—Oedema—Prednisolone—ankylosing spondylitis	7.05e-05	0.00184	CcSEcCtD
Exemestane—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	6.99e-05	0.00182	CcSEcCtD
Exemestane—Cough—Triamcinolone—ankylosing spondylitis	6.93e-05	0.00181	CcSEcCtD
Exemestane—Hypertension—Triamcinolone—ankylosing spondylitis	6.85e-05	0.00179	CcSEcCtD
Exemestane—Hypertension—Methylprednisolone—ankylosing spondylitis	6.84e-05	0.00178	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisolone—ankylosing spondylitis	6.81e-05	0.00178	CcSEcCtD
Exemestane—Myalgia—Triamcinolone—ankylosing spondylitis	6.76e-05	0.00176	CcSEcCtD
Exemestane—Arthralgia—Methylprednisolone—ankylosing spondylitis	6.74e-05	0.00176	CcSEcCtD
Exemestane—Myalgia—Methylprednisolone—ankylosing spondylitis	6.74e-05	0.00176	CcSEcCtD
Exemestane—Anxiety—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.00175	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	6.7e-05	0.00175	CcSEcCtD
Exemestane—Depression—Methotrexate—ankylosing spondylitis	6.69e-05	0.00175	CcSEcCtD
Exemestane—Confusional state—Methylprednisolone—ankylosing spondylitis	6.52e-05	0.0017	CcSEcCtD
Exemestane—Immune system disorder—Prednisone—ankylosing spondylitis	6.51e-05	0.0017	CcSEcCtD
Exemestane—Malaise—Betamethasone—ankylosing spondylitis	6.5e-05	0.0017	CcSEcCtD
Exemestane—Malaise—Dexamethasone—ankylosing spondylitis	6.5e-05	0.0017	CcSEcCtD
Exemestane—Oedema—Triamcinolone—ankylosing spondylitis	6.48e-05	0.00169	CcSEcCtD
Exemestane—Infection—Triamcinolone—ankylosing spondylitis	6.44e-05	0.00168	CcSEcCtD
Exemestane—Sweating—Methotrexate—ankylosing spondylitis	6.43e-05	0.00168	CcSEcCtD
Exemestane—Infection—Methylprednisolone—ankylosing spondylitis	6.42e-05	0.00168	CcSEcCtD
Exemestane—Insomnia—Prednisolone—ankylosing spondylitis	6.37e-05	0.00166	CcSEcCtD
Exemestane—Alopecia—Prednisone—ankylosing spondylitis	6.37e-05	0.00166	CcSEcCtD
Exemestane—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	6.34e-05	0.00166	CcSEcCtD
Exemestane—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	6.34e-05	0.00165	CcSEcCtD
Exemestane—Paraesthesia—Prednisolone—ankylosing spondylitis	6.33e-05	0.00165	CcSEcCtD
Exemestane—Mental disorder—Prednisone—ankylosing spondylitis	6.31e-05	0.00165	CcSEcCtD
Exemestane—Skin disorder—Methylprednisolone—ankylosing spondylitis	6.28e-05	0.00164	CcSEcCtD
Exemestane—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	6.26e-05	0.00163	CcSEcCtD
Exemestane—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	6.25e-05	0.00163	CcSEcCtD
Exemestane—Hypertension—Dexamethasone—ankylosing spondylitis	6.22e-05	0.00162	CcSEcCtD
Exemestane—Hypertension—Betamethasone—ankylosing spondylitis	6.22e-05	0.00162	CcSEcCtD
Exemestane—Myalgia—Betamethasone—ankylosing spondylitis	6.13e-05	0.0016	CcSEcCtD
Exemestane—Myalgia—Dexamethasone—ankylosing spondylitis	6.13e-05	0.0016	CcSEcCtD
Exemestane—Anxiety—Betamethasone—ankylosing spondylitis	6.11e-05	0.00159	CcSEcCtD
Exemestane—Anxiety—Dexamethasone—ankylosing spondylitis	6.11e-05	0.00159	CcSEcCtD
Exemestane—Haemoglobin—Methotrexate—ankylosing spondylitis	6.05e-05	0.00158	CcSEcCtD
Exemestane—Pain—Prednisolone—ankylosing spondylitis	6.03e-05	0.00157	CcSEcCtD
Exemestane—Haemorrhage—Methotrexate—ankylosing spondylitis	6.02e-05	0.00157	CcSEcCtD
Exemestane—Hepatitis—Methotrexate—ankylosing spondylitis	6.02e-05	0.00157	CcSEcCtD
Exemestane—Pharyngitis—Methotrexate—ankylosing spondylitis	5.98e-05	0.00156	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	5.9e-05	0.00154	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	5.89e-05	0.00154	CcSEcCtD
Exemestane—Oedema—Betamethasone—ankylosing spondylitis	5.88e-05	0.00153	CcSEcCtD
Exemestane—Oedema—Dexamethasone—ankylosing spondylitis	5.88e-05	0.00153	CcSEcCtD
Exemestane—Insomnia—Triamcinolone—ankylosing spondylitis	5.86e-05	0.00153	CcSEcCtD
Exemestane—Insomnia—Methylprednisolone—ankylosing spondylitis	5.85e-05	0.00153	CcSEcCtD
Exemestane—Infection—Betamethasone—ankylosing spondylitis	5.84e-05	0.00152	CcSEcCtD
Exemestane—Infection—Dexamethasone—ankylosing spondylitis	5.84e-05	0.00152	CcSEcCtD
Exemestane—Paraesthesia—Triamcinolone—ankylosing spondylitis	5.82e-05	0.00152	CcSEcCtD
Exemestane—Feeling abnormal—Prednisolone—ankylosing spondylitis	5.81e-05	0.00152	CcSEcCtD
Exemestane—Paraesthesia—Methylprednisolone—ankylosing spondylitis	5.81e-05	0.00151	CcSEcCtD
Exemestane—Visual impairment—Methotrexate—ankylosing spondylitis	5.8e-05	0.00151	CcSEcCtD
Exemestane—Dyspnoea—Triamcinolone—ankylosing spondylitis	5.78e-05	0.00151	CcSEcCtD
Exemestane—Nervous system disorder—Dexamethasone—ankylosing spondylitis	5.77e-05	0.0015	CcSEcCtD
Exemestane—Nervous system disorder—Betamethasone—ankylosing spondylitis	5.77e-05	0.0015	CcSEcCtD
Exemestane—Thrombocytopenia—Betamethasone—ankylosing spondylitis	5.76e-05	0.0015	CcSEcCtD
Exemestane—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	5.76e-05	0.0015	CcSEcCtD
Exemestane—Dyspepsia—Triamcinolone—ankylosing spondylitis	5.7e-05	0.00149	CcSEcCtD
Exemestane—Erythema multiforme—Methotrexate—ankylosing spondylitis	5.69e-05	0.00149	CcSEcCtD
Exemestane—Dyspepsia—Methylprednisolone—ankylosing spondylitis	5.69e-05	0.00149	CcSEcCtD
Exemestane—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	5.68e-05	0.00148	CcSEcCtD
Exemestane—Hyperhidrosis—Betamethasone—ankylosing spondylitis	5.68e-05	0.00148	CcSEcCtD
Exemestane—Malaise—Prednisone—ankylosing spondylitis	5.66e-05	0.00148	CcSEcCtD
Exemestane—Anorexia—Betamethasone—ankylosing spondylitis	5.6e-05	0.00146	CcSEcCtD
Exemestane—Anorexia—Dexamethasone—ankylosing spondylitis	5.6e-05	0.00146	CcSEcCtD
Exemestane—Urticaria—Prednisolone—ankylosing spondylitis	5.6e-05	0.00146	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—ankylosing spondylitis	5.59e-05	0.00146	CcSEcCtD
Exemestane—Fatigue—Triamcinolone—ankylosing spondylitis	5.59e-05	0.00146	CcSEcCtD
Exemestane—Fatigue—Methylprednisolone—ankylosing spondylitis	5.57e-05	0.00145	CcSEcCtD
Exemestane—Pain—Triamcinolone—ankylosing spondylitis	5.54e-05	0.00145	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—ankylosing spondylitis	5.44e-05	0.00142	CcSEcCtD
Exemestane—Hypertension—Prednisone—ankylosing spondylitis	5.42e-05	0.00141	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	5.36e-05	0.0014	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	5.36e-05	0.0014	CcSEcCtD
Exemestane—Myalgia—Prednisone—ankylosing spondylitis	5.34e-05	0.00139	CcSEcCtD
Exemestane—Arthralgia—Prednisone—ankylosing spondylitis	5.34e-05	0.00139	CcSEcCtD
Exemestane—Feeling abnormal—Triamcinolone—ankylosing spondylitis	5.34e-05	0.00139	CcSEcCtD
Exemestane—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	5.33e-05	0.00139	CcSEcCtD
Exemestane—Anxiety—Prednisone—ankylosing spondylitis	5.32e-05	0.00139	CcSEcCtD
Exemestane—Alopecia—Methotrexate—ankylosing spondylitis	5.32e-05	0.00139	CcSEcCtD
Exemestane—Insomnia—Dexamethasone—ankylosing spondylitis	5.32e-05	0.00139	CcSEcCtD
Exemestane—Insomnia—Betamethasone—ankylosing spondylitis	5.32e-05	0.00139	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	5.3e-05	0.00138	CcSEcCtD
Exemestane—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	5.29e-05	0.00138	CcSEcCtD
Exemestane—Paraesthesia—Betamethasone—ankylosing spondylitis	5.28e-05	0.00138	CcSEcCtD
Exemestane—Paraesthesia—Dexamethasone—ankylosing spondylitis	5.28e-05	0.00138	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—ankylosing spondylitis	5.28e-05	0.00138	CcSEcCtD
Exemestane—Hypersensitivity—Prednisolone—ankylosing spondylitis	5.19e-05	0.00135	CcSEcCtD
Exemestane—Dyspepsia—Dexamethasone—ankylosing spondylitis	5.18e-05	0.00135	CcSEcCtD
Exemestane—Dyspepsia—Betamethasone—ankylosing spondylitis	5.18e-05	0.00135	CcSEcCtD
Exemestane—Urticaria—Triamcinolone—ankylosing spondylitis	5.15e-05	0.00134	CcSEcCtD
Exemestane—Urticaria—Methylprednisolone—ankylosing spondylitis	5.14e-05	0.00134	CcSEcCtD
Exemestane—Body temperature increased—Triamcinolone—ankylosing spondylitis	5.12e-05	0.00134	CcSEcCtD
Exemestane—Oedema—Prednisone—ankylosing spondylitis	5.12e-05	0.00134	CcSEcCtD
Exemestane—Abdominal pain—Methylprednisolone—ankylosing spondylitis	5.11e-05	0.00133	CcSEcCtD
Exemestane—Decreased appetite—Betamethasone—ankylosing spondylitis	5.11e-05	0.00133	CcSEcCtD
Exemestane—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.11e-05	0.00133	CcSEcCtD
Exemestane—Infection—Prednisone—ankylosing spondylitis	5.09e-05	0.00133	CcSEcCtD
Exemestane—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	5.08e-05	0.00132	CcSEcCtD
Exemestane—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	5.08e-05	0.00132	CcSEcCtD
Exemestane—Back pain—Methotrexate—ankylosing spondylitis	5.07e-05	0.00132	CcSEcCtD
Exemestane—Fatigue—Dexamethasone—ankylosing spondylitis	5.07e-05	0.00132	CcSEcCtD
Exemestane—Fatigue—Betamethasone—ankylosing spondylitis	5.07e-05	0.00132	CcSEcCtD
Exemestane—Pain—Dexamethasone—ankylosing spondylitis	5.03e-05	0.00131	CcSEcCtD
Exemestane—Pain—Betamethasone—ankylosing spondylitis	5.03e-05	0.00131	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—ankylosing spondylitis	5.02e-05	0.00131	CcSEcCtD
Exemestane—Skin disorder—Prednisone—ankylosing spondylitis	4.97e-05	0.0013	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisone—ankylosing spondylitis	4.95e-05	0.00129	CcSEcCtD
Exemestane—Anorexia—Prednisone—ankylosing spondylitis	4.88e-05	0.00127	CcSEcCtD
Exemestane—Feeling abnormal—Betamethasone—ankylosing spondylitis	4.84e-05	0.00126	CcSEcCtD
Exemestane—Feeling abnormal—Dexamethasone—ankylosing spondylitis	4.84e-05	0.00126	CcSEcCtD
Exemestane—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	4.81e-05	0.00125	CcSEcCtD
Exemestane—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	4.81e-05	0.00125	CcSEcCtD
Exemestane—Hypersensitivity—Triamcinolone—ankylosing spondylitis	4.77e-05	0.00125	CcSEcCtD
Exemestane—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	4.76e-05	0.00124	CcSEcCtD
Exemestane—Malaise—Methotrexate—ankylosing spondylitis	4.73e-05	0.00123	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—ankylosing spondylitis	4.69e-05	0.00122	CcSEcCtD
Exemestane—Urticaria—Dexamethasone—ankylosing spondylitis	4.67e-05	0.00122	CcSEcCtD
Exemestane—Urticaria—Betamethasone—ankylosing spondylitis	4.67e-05	0.00122	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	4.66e-05	0.00122	CcSEcCtD
Exemestane—Dizziness—Prednisolone—ankylosing spondylitis	4.66e-05	0.00122	CcSEcCtD
Exemestane—Asthenia—Triamcinolone—ankylosing spondylitis	4.65e-05	0.00121	CcSEcCtD
Exemestane—Body temperature increased—Betamethasone—ankylosing spondylitis	4.65e-05	0.00121	CcSEcCtD
Exemestane—Abdominal pain—Betamethasone—ankylosing spondylitis	4.65e-05	0.00121	CcSEcCtD
Exemestane—Abdominal pain—Dexamethasone—ankylosing spondylitis	4.65e-05	0.00121	CcSEcCtD
Exemestane—Body temperature increased—Dexamethasone—ankylosing spondylitis	4.65e-05	0.00121	CcSEcCtD
Exemestane—Asthenia—Methylprednisolone—ankylosing spondylitis	4.64e-05	0.00121	CcSEcCtD
Exemestane—Insomnia—Prednisone—ankylosing spondylitis	4.63e-05	0.00121	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—ankylosing spondylitis	4.6e-05	0.0012	CcSEcCtD
Exemestane—Pruritus—Triamcinolone—ankylosing spondylitis	4.58e-05	0.0012	CcSEcCtD
Exemestane—Cough—Methotrexate—ankylosing spondylitis	4.57e-05	0.00119	CcSEcCtD
Exemestane—Pruritus—Methylprednisolone—ankylosing spondylitis	4.57e-05	0.00119	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—ankylosing spondylitis	4.51e-05	0.00118	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—ankylosing spondylitis	4.46e-05	0.00116	CcSEcCtD
Exemestane—Chest pain—Methotrexate—ankylosing spondylitis	4.46e-05	0.00116	CcSEcCtD
Exemestane—Myalgia—Methotrexate—ankylosing spondylitis	4.46e-05	0.00116	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—ankylosing spondylitis	4.45e-05	0.00116	CcSEcCtD
Exemestane—Rash—Prednisolone—ankylosing spondylitis	4.44e-05	0.00116	CcSEcCtD
Exemestane—Dermatitis—Prednisolone—ankylosing spondylitis	4.44e-05	0.00116	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	4.43e-05	0.00116	CcSEcCtD
Exemestane—Diarrhoea—Methylprednisolone—ankylosing spondylitis	4.42e-05	0.00115	CcSEcCtD
Exemestane—Fatigue—Prednisone—ankylosing spondylitis	4.41e-05	0.00115	CcSEcCtD
Exemestane—Headache—Prednisolone—ankylosing spondylitis	4.41e-05	0.00115	CcSEcCtD
Exemestane—Constipation—Prednisone—ankylosing spondylitis	4.38e-05	0.00114	CcSEcCtD
Exemestane—Confusional state—Methotrexate—ankylosing spondylitis	4.31e-05	0.00113	CcSEcCtD
Exemestane—Dizziness—Triamcinolone—ankylosing spondylitis	4.28e-05	0.00112	CcSEcCtD
Exemestane—Dizziness—Methylprednisolone—ankylosing spondylitis	4.28e-05	0.00112	CcSEcCtD
Exemestane—Infection—Methotrexate—ankylosing spondylitis	4.25e-05	0.00111	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—ankylosing spondylitis	4.22e-05	0.0011	CcSEcCtD
Exemestane—Asthenia—Betamethasone—ankylosing spondylitis	4.22e-05	0.0011	CcSEcCtD
Exemestane—Asthenia—Dexamethasone—ankylosing spondylitis	4.22e-05	0.0011	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—ankylosing spondylitis	4.2e-05	0.0011	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.19e-05	0.00109	CcSEcCtD
Exemestane—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.19e-05	0.00109	CcSEcCtD
Exemestane—Nausea—Prednisolone—ankylosing spondylitis	4.19e-05	0.00109	CcSEcCtD
Exemestane—Pruritus—Betamethasone—ankylosing spondylitis	4.16e-05	0.00109	CcSEcCtD
Exemestane—Pruritus—Dexamethasone—ankylosing spondylitis	4.16e-05	0.00109	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—ankylosing spondylitis	4.16e-05	0.00108	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.14e-05	0.00108	CcSEcCtD
Exemestane—Vomiting—Triamcinolone—ankylosing spondylitis	4.12e-05	0.00108	CcSEcCtD
Exemestane—Vomiting—Methylprednisolone—ankylosing spondylitis	4.11e-05	0.00107	CcSEcCtD
Exemestane—Rash—Triamcinolone—ankylosing spondylitis	4.09e-05	0.00107	CcSEcCtD
Exemestane—Dermatitis—Triamcinolone—ankylosing spondylitis	4.08e-05	0.00107	CcSEcCtD
Exemestane—Anorexia—Methotrexate—ankylosing spondylitis	4.08e-05	0.00106	CcSEcCtD
Exemestane—Rash—Methylprednisolone—ankylosing spondylitis	4.08e-05	0.00106	CcSEcCtD
Exemestane—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.07e-05	0.00106	CcSEcCtD
Exemestane—Urticaria—Prednisone—ankylosing spondylitis	4.07e-05	0.00106	CcSEcCtD
Exemestane—Headache—Triamcinolone—ankylosing spondylitis	4.06e-05	0.00106	CcSEcCtD
Exemestane—Headache—Methylprednisolone—ankylosing spondylitis	4.05e-05	0.00106	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—ankylosing spondylitis	4.05e-05	0.00106	CcSEcCtD
Exemestane—Body temperature increased—Prednisone—ankylosing spondylitis	4.05e-05	0.00106	CcSEcCtD
Exemestane—Diarrhoea—Betamethasone—ankylosing spondylitis	4.02e-05	0.00105	CcSEcCtD
Exemestane—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.02e-05	0.00105	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	3.9e-05	0.00102	CcSEcCtD
Exemestane—Dizziness—Dexamethasone—ankylosing spondylitis	3.89e-05	0.00101	CcSEcCtD
Exemestane—Dizziness—Betamethasone—ankylosing spondylitis	3.89e-05	0.00101	CcSEcCtD
Exemestane—Insomnia—Methotrexate—ankylosing spondylitis	3.87e-05	0.00101	CcSEcCtD
Exemestane—Nausea—Triamcinolone—ankylosing spondylitis	3.85e-05	0.001	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—ankylosing spondylitis	3.84e-05	0.001	CcSEcCtD
Exemestane—Nausea—Methylprednisolone—ankylosing spondylitis	3.84e-05	0.001	CcSEcCtD
Exemestane—Dyspnoea—Methotrexate—ankylosing spondylitis	3.81e-05	0.000996	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—ankylosing spondylitis	3.77e-05	0.000984	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—ankylosing spondylitis	3.77e-05	0.000983	CcSEcCtD
Exemestane—Vomiting—Dexamethasone—ankylosing spondylitis	3.74e-05	0.000975	CcSEcCtD
Exemestane—Vomiting—Betamethasone—ankylosing spondylitis	3.74e-05	0.000975	CcSEcCtD
Exemestane—Decreased appetite—Methotrexate—ankylosing spondylitis	3.72e-05	0.000971	CcSEcCtD
Exemestane—Rash—Dexamethasone—ankylosing spondylitis	3.71e-05	0.000967	CcSEcCtD
Exemestane—Rash—Betamethasone—ankylosing spondylitis	3.71e-05	0.000967	CcSEcCtD
Exemestane—Dermatitis—Betamethasone—ankylosing spondylitis	3.7e-05	0.000966	CcSEcCtD
Exemestane—Dermatitis—Dexamethasone—ankylosing spondylitis	3.7e-05	0.000966	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	3.69e-05	0.000964	CcSEcCtD
Exemestane—Fatigue—Methotrexate—ankylosing spondylitis	3.69e-05	0.000963	CcSEcCtD
Exemestane—Headache—Dexamethasone—ankylosing spondylitis	3.68e-05	0.000961	CcSEcCtD
Exemestane—Headache—Betamethasone—ankylosing spondylitis	3.68e-05	0.000961	CcSEcCtD
Exemestane—Asthenia—Prednisone—ankylosing spondylitis	3.67e-05	0.000959	CcSEcCtD
Exemestane—Pain—Methotrexate—ankylosing spondylitis	3.66e-05	0.000955	CcSEcCtD
Exemestane—Pruritus—Prednisone—ankylosing spondylitis	3.62e-05	0.000945	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—ankylosing spondylitis	3.53e-05	0.00092	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—ankylosing spondylitis	3.5e-05	0.000914	CcSEcCtD
Exemestane—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	3.5e-05	0.000913	CcSEcCtD
Exemestane—Nausea—Betamethasone—ankylosing spondylitis	3.49e-05	0.000911	CcSEcCtD
Exemestane—Nausea—Dexamethasone—ankylosing spondylitis	3.49e-05	0.000911	CcSEcCtD
Exemestane—Urticaria—Methotrexate—ankylosing spondylitis	3.4e-05	0.000887	CcSEcCtD
Exemestane—Dizziness—Prednisone—ankylosing spondylitis	3.39e-05	0.000884	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—ankylosing spondylitis	3.38e-05	0.000883	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—ankylosing spondylitis	3.38e-05	0.000883	CcSEcCtD
Exemestane—Vomiting—Prednisone—ankylosing spondylitis	3.26e-05	0.00085	CcSEcCtD
Exemestane—Rash—Prednisone—ankylosing spondylitis	3.23e-05	0.000842	CcSEcCtD
Exemestane—Dermatitis—Prednisone—ankylosing spondylitis	3.23e-05	0.000842	CcSEcCtD
Exemestane—Headache—Prednisone—ankylosing spondylitis	3.21e-05	0.000837	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.15e-05	0.000823	CcSEcCtD
Exemestane—Asthenia—Methotrexate—ankylosing spondylitis	3.07e-05	0.000801	CcSEcCtD
Exemestane—Nausea—Prednisone—ankylosing spondylitis	3.04e-05	0.000794	CcSEcCtD
Exemestane—Pruritus—Methotrexate—ankylosing spondylitis	3.03e-05	0.00079	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—ankylosing spondylitis	2.93e-05	0.000764	CcSEcCtD
Exemestane—Dizziness—Methotrexate—ankylosing spondylitis	2.83e-05	0.000738	CcSEcCtD
Exemestane—Vomiting—Methotrexate—ankylosing spondylitis	2.72e-05	0.00071	CcSEcCtD
Exemestane—Rash—Methotrexate—ankylosing spondylitis	2.7e-05	0.000704	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—ankylosing spondylitis	2.7e-05	0.000703	CcSEcCtD
Exemestane—Headache—Methotrexate—ankylosing spondylitis	2.68e-05	0.0007	CcSEcCtD
Exemestane—Nausea—Methotrexate—ankylosing spondylitis	2.54e-05	0.000663	CcSEcCtD
